BioCentury
ARTICLE | Clinical News

Ilex Oncology begins Phase I

March 21, 2000 8:00 AM UTC

ILXO began a second Phase I trial of its ILX23-7553 vitamin D3 analog to treat cancer. The 35-patient trial will evaluate the optimal dosage, safety and potential to treat refractory solid tumors of I...